Join Ziccum CEO Ann Gidner for ‘Invest Live’, a live digital presentation and Q&A, Tues Feb 6th

Join Ziccum CEO Ann Gidner on Tuesday 6 February for ‘Invest live’ as she presents Ziccum’s unique technology for biopharmaceuticals and its ground-breaking new mRNA data at a live digital event with Investor Target. Participants may post questions ahead of the event and watch live at the link below.

At 12.00 noon on Tuesday February 6 Ziccum CEO Ann Gidner will present the Company at “Invest Live” hosted by Investor Target analyst Kaarlo Airaxin. The event will take place in Swedish.

Ann will cover Ziccum’s formulating and drying technology LaminarPace, how it can turn delicate vaccines and biologics including mNRA into robust thermostable dry powders, the market opportunity for this, and the Company’s outstanding performance over the last 18 months.

Mail your questions ahead of the event here: kaarlo.airaxin@investortarget.se

Watch the event live here: https://youtube.com/live/qldbpqBV8Js?feature=share